Chart, page-2611

Agree with you T. I believe in buying on fundamentals too.

But in these situations we are currently in, some stocks (like ZNO) will trade at a premium. I do not know how big the premium is, it could be 50% or even 100% to other bio stocks. This is not a text book valuation case in my view.

Another way to look at this is - how much a co like RB would pay to buyout a co like ZNO? $500m feels too little. This really scares the sxxx out of me.

Are you able to share your latest estimates (if you have changed from last you posted) of ZNO FY21 revenue please. You are much better at these than me ! Thanks

Thanks

PC